Analysis of QT Interval Prolongation of Amiselimod in Healthy Subjects: A Phase 1 Randomized Controlled Trial

被引：0
|
作者：
Vivian, Lee [1 ]
Omeed, Alipour [2 ]
Tapas, Tejura [1 ]
Melissa, Wilson [1 ]
Zoe, Memel [3 ]
Kyle, Cologne [1 ]
Caroline, Hwang [4 ]
Ling, Shao [1 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Hoag Hosp, Newport Beach, CA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
10.14309/01.ajg.0000722852.81814.04
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P014
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [41] CONFIRMATION OF QT PROLONGATION BY ORAL MOXIFLOXACIN IN HEALTHY JAPANESE SUBJECTS FOR THOROUGH QT/QTC STUDIES IN JAPAN
    Kumagai, Y.
    Ikeda, Y.
    Fujita, T.
    Sahashi, K.
    Saikawa, T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 102 - 102
  • [42] Physiological predictors of the magnitude of sotalol-induced QT interval prolongation in healthy volunteers
    Chenai, C.
    Alvarez, J. C.
    Ciuchete, A.
    Hulot, J. S.
    Funck-Brentano, C.
    Charbit, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 33 - 34
  • [43] Entropy Analysis of RR and QT Interval Variability during Orthostatic and Mental Stress in Healthy Subjects
    Baumert, Mathias
    Czippelova, Barbora
    Ganesan, Anand
    Schmidt, Martin
    Zaunseder, Sebastian
    Javorka, Michal
    ENTROPY, 2014, 16 (12): : 6384 - 6393
  • [44] Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial
    Liu, Xiaoyan
    Zhang, Rui
    Li, Rong
    Wu, Qiong
    Pan, Chao
    Yu, Xiangqing
    Liu, Yuhui
    Wang, Benjie
    Yu, Shuwen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (12)
  • [45] Filgotinib, a Selective Janus Kinase 1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects
    Anderson, Kacey
    Zheng, Hao
    Yun, Chohee
    Kwan, Ellen
    Qin, Ann
    Namour, Florence
    Kearney, Brian P.
    Xin, Yan
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [46] Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects
    Davis, John D.
    Hackman, Frances
    Layton, Gary
    Higgins, Tracy
    Sudworth, David
    Weissgerber, Georges
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 : 68 - 75
  • [47] Concentration QT Interval Modeling of Intranasally Administered Zavegepant in Healthy Subjects
    Bertz, Richard
    Stringfellow, Joseph
    Bhardwaj, Rajinder
    Donohue, Mary
    Madonia, Jennifer
    Anderson, Matt
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    NEUROLOGY, 2023, 100 (17)
  • [48] EVALUATION OF THE EFFECT OF MOMELOTINIB ON THE QT/QTC INTERVAL IN HEALTHY SUBJECTS.
    Xin, Y.
    Jun, S.
    Moorehead, L.
    Kwan, E.
    Hepner, M.
    Ramanathan, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S32 - S32
  • [49] Analysis of QT interval prolongation with heart failure by simulation of repolarization process
    Yamaguchi, T.
    Arafune, T.
    Sakuma, I.
    Watanabe, E.
    Shibata, N.
    Honjo, H.
    Kodama, I.
    Kamiya, K.
    2005 27TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7, 2005, : 7309 - 7312
  • [50] No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects
    Mu, Song
    Darpo, Borje
    Tang, Zhiyu
    Novotny, William
    Tawashi, Manal
    Xue, Hongqi
    Willett, Michael
    Lin, Leo
    Sahasranaman, Sri
    Ou, Ying C.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05): : 923 - 931
12345